LAB FY 2024 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$174M+64.0% YoY

Gross Profit

$84M48.3% margin

Operating Income

-$175M-100.5% margin

Net Income

-$139M-79.6% margin

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$143M

Free Cash Flow

-$152M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$612M

Total Liabilities

$141M

Stockholders' Equity

$472M

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174M	$106M	+64.0%
Gross Profit	$84M	$50M	+67.0%
Operating Income	-$175M	-$77M	-128.8%
Net Income	-$139M	-$75M	-86.0%